期刊文献+

N-三甲基壳聚糖包衣的盐酸阿霉素脂质体的制备 被引量:8

Preparation of Adriamycin Liposomes Coated by N-trimethyl Chitosan
下载PDF
导出
摘要 目的:研制N-三甲基壳聚糖(TMC)包衣的盐酸阿霉素(ADM)脂质体。方法:采用硫酸铵梯度法制备ADM脂质体,以包封率为指标,筛选盐酸阿霉素脂质体最佳处方;合成不同季铵化程度的TMC,并对最佳ADM脂质体进行包衣。结果:未包衣ADM脂质体平均粒径为(378.6±5.2)nm,Zeta电位为(-62.08±2.5)mv,平均包封率为(62.27±1.75)%(n=3)。TMC包衣后,脂质体粒径增大,并随着TMC季铵化程度的增大,Zeta电位显著增大(P<0.05);TMC20、TMC40、TMC60包衣脂质体体外释药曲线符合Higuchi方程,分别为:Q=7.6315+3.7863t_(1/2)(r=0.929 2),Q=6.9647+3.5709t_(1/2)(r=0.9318),Q= 7.3451+2.7665t_(1/2)(r=0.935 7)。结论:TMC包衣ADM脂质体的制备工艺可行,其表面带有较高正电性,为下一步研究其血管靶向性打下基础。 To prepare adriamycin (ADM) liposomes coated by N-trimethyl chitosan (TMC). Method: Ammonium sulphate gradient method was used for preparation of ADM liposomes and entrapment efficiency was the index to screen the optimal prescription of ADM liposomes. The TMC with different degree of quarternization (DQ) were synthesed followed by the optimal prescription of ADM liposomes was coated. Result: Mean diameter of ADM liposomes before coated was 378.6nm ± 5.2nm, the zeta potential was ( - 62.08 ± 2.5 ) mv and mean entrapment efficiency was ( 62.27 ± 1.75 ) % ( n = 3 ). The particle size of ADM liposomes was increased after coated by TMC. As the increase of DQ of TMC, the zeta potential of TMC-coated ADM liposomes was increased remarkably (P 〈 0.05 ). The release of TMC20 ,TMC40 and TMC60-coated ADM liposomes in vitro were accorded with the Higuehi equation, respectively: Q = 7.6315 + 3. 7863t11/2 ( r = 0. 929 2 ), Q = 6. 9647 + 3. 5709t1/2 ( r = 0.931 8 ), Q = 7.3451 + 2.7665t1/2 ( r = 0. 935 7 ). Conclusion: The preparation of ADM liposomes coated by different DQ of TMC is feasible. Their positive zeta potential is the basis of the luther study on tumor neovasculature target.
出处 《中国药师》 CAS 2009年第1期39-42,共4页 China Pharmacist
关键词 N-三甲基壳聚糖 阿霉素 脂质体 硫酸铵梯度法 包衣 N-trimethyl chitosan Adriamycin Liposomes Ammonium sulphate gradient method Coating
  • 相关文献

参考文献15

  • 1Ran S , He J , Huang XM , et al. Antitumor effects of a monoclonal antiboby that binds anionic phospholipids on the surface of tumor blood vessels in mice [ J ]. Clinical Cancer Research, 2005,11 : 1151-1162.
  • 2Mounkes LC, Zhong W, Cipres-Palacin G, et al. Proteoglyeans mediate cationic liposome-DNA complex-based gene deliver), in vitro and in vivo [ J ]. Biol Chern , 1998,273:26164-26170.
  • 3Augustin HG , Kozian DH , Johson RC. Differentiation of endothelial cells : analysis of the constructive and activated endothelial cells phenotypes [ J ]. Bioessays, 1994,16:901-906.
  • 4Kunsffeld R , Wickenhauser G , Michaelis U , et al. Paclitaxe encapsulated in cati-onie liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model [ J ]. Invest Dermatol, 2003,120:476-482.
  • 5Strieth S , Eichhorn ME , Sauer B , et al. Neovascular targeting chemotherapy : encapsulation of paclitaxe in cationic liposomes impair functional tumor microvascu lature [ J ]. Int J Cancer, 2004,110 : 117-124.
  • 6Sandri G, Rossi S, Bonferoni MC, et al. Buccal penetration enhancement properties of N-trimethyl chitosan : Influence of quaternization deggre on absorption of a high molecular weight molecule [ J ]. Intemizational Journal of Pharmaceutics ,2005,297 : 146-155.
  • 7Jonker C, Hamman JH, Kotze AF. Intestinal paracellular permeation enhancement with quaternised chitosan: in situ and in vitro evalution [ J ]. International Journal of Pharmaceutics, 2002,238 : 205 -213.
  • 8Snyrnan D, Hamman JH,Kotze JS,et al. The relationship between the absolute molecuar weight and the deggre of quatemisation of N-trimethyl chitosan chloide [ J ]. Carbohydrate polymers, 2002,50 ( 2 ) : 145 - 150.
  • 9Sieval AB,Thanou M, Kotze AF,et al. Preparation and NMR-eharaeterization of highly substituted N-trimethyl chitosan choride[ J ]. Carbohydr Polym, 1998, (36) :157-165.
  • 10Bowe CL, Venkatesan P. Design of compounds that increase the absorption of polar molecules[ J]. Proc Natl Acad Sci, 1997,94 : 12218-12223.

二级参考文献31

  • 1Harrington KJ, Rowlinson-Busza G, Syrigos KN. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies [J]. Br J Cancer, 2000,83(2):232-238.
  • 2Sihorkar V, Vyas SP. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization [J]. J Pharm Sci, 2001,4(2):138-158.
  • 3Budai M, Szogyi M. Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes [J]. Acta Pharm Hung, 2001,71(1):114-118.
  • 4Edwards C. Physiology of the colorectal barrier [J]. Adv Drug Deliv Rev, 1997,28:173-190.
  • 5Roger CC. New Liposomes: a Practice Approach [M]. Oxford: Oxford University Press, 1994.108-109.
  • 6Schreiber AB, Haimovich J. Quantitative fluorometric assay for detection and characterization of Fc receptor [J]. Methods Enzymol, 1983,93:147-155.
  • 7Grcic FJ, Basnet S. Mucoadhesive chitosan-coated liposomes:characteristics and stability [J]. J Microencapsul, 2001,18(1):3-12.
  • 8Lamprecht A, Schfer U, Lehr CM. Structural analysis of microparticles by confocal laser scanning microscopy [J]. AAPS Pharm Sci Tech, 2000,1(3):article 17.
  • 9Lamprecht A, Schfer U, Lehr CM. Characterization of microcapsules by confocal laser scanning microscopy: structure, capsule wall composition and encapsulation rate [J]. Eur J Pharm Biopharm, 2000,49(1):1-9.
  • 10Henriken I, Smistad G, Karsen J. Interaction between liposomes and chitosan [J]. Int J Pharm, 1994,101:227-236.

共引文献66

同被引文献92

引证文献8

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部